SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-047496
Filing Date
2022-08-12
Accepted
2022-08-12 17:01:31
Documents
50
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_actiniumpharma.htm   iXBRL 10-Q 812113
2 EXCLUSIVE LICENSE AND SUPPLY AGREEMENT, DATED APRIL 7, 2022, BETWEEN IMMEDICA PH f10q0622ex10-1_actinium.htm EX-10.1 346333
3 SUBLEASE AGREEMENT, DATED APRIL 28, 2022, BETWEEN ABN AMRO HOLDINGS USA LLC AND f10q0622ex10-2_actinium.htm EX-10.2 80291
4 CERTIFICATION f10q0622ex31-1_actinium.htm EX-31.1 10655
5 CERTIFICATION f10q0622ex31-2_actinium.htm EX-31.2 11175
6 CERTIFICATION f10q0622ex32-1_actinium.htm EX-32.1 4401
7 CERTIFICATION f10q0622ex32-2_actinium.htm EX-32.2 4755
  Complete submission text file 0001213900-22-047496.txt   3866748

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE atnm-20220630.xsd EX-101.SCH 38314
9 XBRL CALCULATION FILE atnm-20220630_cal.xml EX-101.CAL 22969
10 XBRL DEFINITION FILE atnm-20220630_def.xml EX-101.DEF 145678
11 XBRL LABEL FILE atnm-20220630_lab.xml EX-101.LAB 337088
12 XBRL PRESENTATION FILE atnm-20220630_pre.xml EX-101.PRE 157485
44 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_actiniumpharma_htm.xml XML 281731
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 221161054
SIC: 2834 Pharmaceutical Preparations